Novo Nordisk now wants Sun Pharma to stop dealing in weight loss drug compound, goes to Delhi HC again

Danish pharma giant says in process of challenging earlier verdict, where court allowed Dr Reddy’s to make and export weight-loss drug Danish pharma giant Novo Nordisk has moved the Delhi…

Dr Reddy’s inks licensing deal to sell Immutep’s cancer drug

Dr Reddy’s has signed an exclusive licensing deal with Australia’s Immutep to make, develop and distribute the company’s cancer treatment, according to a stock exchange filing on Monday. The agreement,…

Mandatory QR code for med allergic reactions: Pharma body to start drive

Kolkata: After a lukewarm response from retailers across the state regarding the display of QR codes to report adverse drug reactions, the pharma-retail body in the state has decided to…

Odisha Approves Pharma & MedTech Policy to Build Sector Hubs & Boost Investment

The new policy will help Odisha build a competitive ecosystem for pharmaceutical and MedTech manufacturing, offering investors modern infrastructure, incentives and streamlined approvals to scale operations. The Odisha Cabinet has…

Haryana doctors’ strike: What’s triggering the two-day shutdown in government hospitals?

Healthcare services across Haryana are set to suffer major disruption as doctors under the Haryana Civil Medical Services Association (HCMSA) go on a two-day strike on 8 and 9 December.…

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

The report emphasizes that absolute R&D spending remains modest and identifies expanding investment in advanced biologics and AI-driven drug discovery as the “largest opportunity” for bridging the innovation divide. Recent…

India headed for Culture of ‘Divya Buildings’, thanks to AMTZ’s Landmark Initiative

Nitin Gadkari launches World’s Largest Medtech Cluster’s ‘Purple Device’ for certifying Barrier Free Buildings New Delhi: Acquiescing in a sober fact that International standards in whatever India manufactures or builds…

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

Early-stage activity drove the month, accounting for 73.6 per cent of total investments, while seed-stage rounds contributed the remaining 26.4 per cent. India’s pharma and healthcare funding for November 2025…

Novo Nordisk gears up for December Ozempic launch

Danish drug maker Novo Nordisk will launch its blockbuster diabetes drug Ozempic in India this month, three sources familiar with the matter said, as it seeks to strengthen its foothold…

Illegal intoxicant tablets seized in large quantity from Sirsa medical store, two held

State Drug Controller Lalit Goyal informed that in compliance with the orders of the State Health Minister Arti Singh Rao, a swift action is being taken against those involved in…